No Data
No Data
Trump's Tariff Moves: Market Stabilization Amid Uncertainty and the Road Ahead
Cathie Wood's ARK Investment Buys 161K Shares of Recursion Pharmaceuticals Today
Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today
Recursion Pharmaceuticals (NasdaqGS:RXRX) Jumps 12% Following US$500M Equity Offering
Recursion Pharma Down 37% in a Month: Buy, Sell or Hold the Stock?
Press Release: Recursion Bolsters Board of Directors With Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun